GDF11/BMP11 activates both smad1/5/8 and smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells
Yonghui Zhang; Feng Cheng; Xueting Du; Jin‐Lai Gao; Xiaolin Xiao; Na Li; Shanliang Li; De‐Li Dong · 2016 · Oncotarget
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract
// Yong-Hui Zhang 1 , Feng Cheng 1 , Xue-Ting Du 1 , Jin-Lai Gao 1 , Xiao-Lin Xiao 1 , Na Li 1 , Shan-Liang Li 1 and De-Li Dong 1 1 Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin Medical University, Harbin, P.R.China Correspondence to: De-Li Dong, email: // Keywords : bone morphogenetic protein 11, growth differentiation factor 11, smad2/3, smad1/5/8,
Abstract by Yonghui Zhang; Feng Cheng; Xueting Du; Jin‐Lai Gao; Xiaolin Xiao; Na Li; Shanliang Li; De‐Li Dong, Oncotarget (2016) — licensed CC BY 4.0.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Negative / Null Result ReportDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Negative / Null Result ReportStenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
Negative / Null Result ReportEffects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Replication FailureA Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Negative / Null Result ReportSpironolactone for Heart Failure with Preserved Ejection Fraction
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: OpenAlex · DOI 10.18632/oncotarget.7642
